Overview

From our site in Charles City, Iowa, USA, we develop and manufacture small molecule APIs, fine chemicals and intermediates for a wide range of applications.

Home to a team of more than 350 employees, the site is comprised of four large scale commercial cGMP production plants, as well as a cGMP pilot plant and cGMP kilo laboratory.

From our Charles City facility, we currently produce more than 40 APIs per year across our multi-purpose production units.

Our site is also equipped to handle controlled substances, with potent compound development, manufacturing, drying and packaging capabilities.

The facility is one of a limited number to be authorized by the Drug Enforcement Administration (DEA) to import narcotic raw materials at commercial scale.

Facility details

  • 4 cGMP commercial scale production plants
  • 1 cGMP pilot plant
  • 1 cGMP kilo laboratory
  • 350,000L commercial capacity
  • R&D development and analytical laboratories
  • High potency development and manufacturing center
  • Strong regulatory history